| Literature DB >> 32806771 |
Sylvia Maina1,2,3, Gerald Misinzo2,3, Gaymary Bakari2, Ho-Youn Kim1.
Abstract
Glucosinolates (GSs) are common anionic plant secondary metabolites in the order Brassicales. Together with glucosinolate hydrolysis products (GSHPs), they have recently gained much attention due to their biological activities and mechanisms of action. We review herein the health benefits of GSs/GSHPs, approaches to improve the plant contents, their bioavailability and bioactivity. In this review, only literature published between 2010 and March 2020 was retrieved from various scientific databases. Findings indicate that these compounds (natural, pure, synthetic, and derivatives) play an important role in human/animal health (disease therapy and prevention), plant health (defense chemicals, biofumigants/biocides), and food industries (preservatives). Overall, much interest is focused on in vitro studies as anti-cancer and antimicrobial agents. GS/GSHP levels improvement in plants utilizes mostly biotic/abiotic stresses and short periods of phytohormone application. Their availability and bioactivity are directly proportional to their contents at the source, which is affected by methods of food preparation, processing, and extraction. This review concludes that, to a greater extent, there is a need to explore and improve GS-rich sources, which should be emphasized to obtain natural bioactive compounds/active ingredients that can be included among synthetic and commercial products for use in maintaining and promoting health. Furthermore, the development of advanced research on compounds pharmacokinetics, their molecular mode of action, genetics based on biosynthesis, their uses in promoting the health of living organisms is highlighted.Entities:
Keywords: bioactivity; bioavailability; glucosinolate hydrolysis products; glucosinolates; improvement; natural compounds; secondary metabolites
Mesh:
Substances:
Year: 2020 PMID: 32806771 PMCID: PMC7464879 DOI: 10.3390/molecules25163682
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1This figure shows the flowchart used in the article selection process.
Various health benefits of GSs and GSHPs.
| GSs | Hydrolysis Product | Biological Activity | Source | Organism/Pathogen/ Cell | Reference |
|---|---|---|---|---|---|
|
| |||||
|
| |||||
| Glucoraphanin, glucoiberin glucobrassicanapin, glucoerucin | Sulforaphane | Biocide | Synthetic | [ | |
| Sinigrin | Allyl ITCs/2-propenyl ITCs | Herbicidal | Synthetic L. | [ | |
| Nematicidal activity |
|
| [ | ||
| Insecticidal | synthetic |
| [ | ||
| Biocide | Synthetic | [ | |||
| Nematicidal activity |
| [ | |||
| Biofumigation |
|
| [ | ||
| Fungitoxic activity | Synthetic |
| [ | ||
| Gluconapin | Butyl ITCs | Fungitoxic activity | Synthetic |
| [ |
| Biocide | [ | ||||
| Glucocapparin | Methyl ITCs | Fungitoxic activity | Synthetic |
| [ |
| Weed germination inhibition |
| [ | |||
|
| |||||
| Sinigrin | Antimicrobial | [ | |||
| Antibacterial |
| [ | |||
| Antifungal |
|
| [ | ||
| Antimicrobial |
|
| [ | ||
| Antimicrobial | Cruciferous plant | methicillin resistant S | [ | ||
| Antimicrobial and cytotoxic |
| [ | |||
| Synthetic | [ | ||||
| Antimicrobial | Synthetic |
| [ | ||
| Antimicrobial activity |
|
| [ | ||
| Antimicrobial |
|
| [ | ||
| Bactericidal | synthetic |
| [ | ||
| Glucoraphanin | 4-(Methylsulfanyl)butyl ITCs & 5-(methylsulfanyl)pentanenitrile | Antimicrobial |
| [ | |
| Antibacterial | Synthetic | Pig aeromonas intestinal bacteria | [ | ||
| Gluconapin | 3-Butenyl ITCs | Antimicrobial |
|
| [ |
| Antimicrobial activity |
|
| [ | ||
| Antimicrobial |
|
| [ | ||
| Glucoerucin | 4-(Methylsulfanyl)butyl ITCs, 5-(methylsulfanyl)pentanenitrile | Antimicrobial |
| [ | |
| Antimicrobial activity |
|
| [ | ||
| Antimicrobial |
| [ | |||
| Glucobrassicanapin | Antimicrobial |
| Gram positive, negative bacteria and fungi | [ | |
|
|
| [ | |||
| Glucoalyssin | Antimicrobial |
|
| [ | |
| Glucoiberverin | Antimicrobial activity |
|
| [ | |
| Glucoberteroin | 6-(Methylsulfanyl) hexanenitrile | Antimicrobial |
| [ | |
| aliphatic ITCs and their derivatives | Antimicrobial | Synthetic |
| [ | |
|
| |||||
| Sinigrin | Allyl ITCs | Antioxidant | [ | ||
| [ | |||||
| Curly kale leaves | [ | ||||
| Gluconapin | Antioxidant | [ | |||
| Glucoalyssin, progoitrin, glucobrassicanapin, | Antioxidant | [ | |||
| Glucoiberin | Antioxidant | Curly kale leaves | [ | ||
|
| |||||
| Sinigrin | Allyl ITCs | Anti-inflammatory | Synthetic | [ | |
|
| [ | ||||
| Glucoraphanin | Sulforaphane | Inflammatory Prophylactic | Broccoli sprouts | [ | |
| Anti-inflammatory | Broccoli sprouts | [ | |||
| Tuscan blackkale | [ | ||||
|
| [ | ||||
| Neoglucobrassicin | Anti-inflammatory | synthetic | [ | ||
|
| |||||
| Gluconapin, | But-3-enyl ITCs | Acetylcholinesterase inhibitory activity |
| [ | |
|
| |||||
| Sinigrin | Allyl ITCs | Quinone reductase activity |
| Hepa1c1c7 murine hepatoma cells | [ |
| Cytotoxicity | Synthetic | MCL-5 cells | [ | ||
| Anti-cancer, radical scavenging ability and increase ROS | human breast cancer (MCF-7, MDA-MB-231), prostate cancer (PC-3), lung cancer (A-549), cervical cancer (HeLa) and colon cancer (HCT 116) cells | [ | |||
| Anti-cancer | Mustard seed powder | bladder cancer cell lines and orthotopic rats model bladder | [ | ||
| Cytotoxic | Glioblastoma LN229 cells | [ | |||
| Anti-cancer, anti-melanoma | HepG2 human liver carcinoma and BB16F10 mice melanoma cells | [ | |||
| Anti-tumor | Collard | Human MCF-7, HeLa cells | [ | ||
| Anti-proliferative | colon HCT 116 and HT-29 cells | [ | |||
| Anti-tumor | Collard | Human MCF-7 and HeLa cells | [ | ||
| Glucoraphanin | Sulforaphane | Chemoprevention |
| Liver and lung cells | [ |
| Chemoprevention | Japanese Daikon | Rats liver and lung | [ | ||
| Anti-multiple myeloma activity | Synthetic | Myeloma cells | [ | ||
| Chemoprevention |
| Human HepG2 hepatoma cells | [ | ||
| Anti-cancer, anti-melanoma | HepG2 human liver carcinoma, BB16F10 mice melanoma cells | [ | |||
| Quinone reductase activity | Chinese kales | Hepa 1c1c7 murine hepatoma cells | [ | ||
| Quinone reductase activity | murine hepatoma Hepa1c1c7 cells | [ | |||
| Anti-metastatic | Synthetic | MDA-MB-231(breast), Caski (cervical), A549 (lung), and U2OS (osteosarcoma) cell lines | [ | ||
| Anti-cancer | Synthetic | breast cancer cell | [ | ||
| inhibit cancer cells DNA replication | Synthetic | PC-3 prostate cancer cells | [ | ||
| upregulating detoxification enzymes | Synthetic | Mouse cortical neurons | [ | ||
| Chemoprevention | Japanese Daikon | Rats liver and lung | [ | ||
| Chemoprotection | Synthetic | Human colon cancer cells | [ | ||
| histone deacetylase activity | Broccoli sproutssupplement | Dog | [ | ||
| Glucoraphenin | Sulforaphene | Cytotoxic and cell apoptosis | Human hepatocarcinoma HepG2 cells | [ | |
| Glucoraphasatin | Raphasitin | Enzyme detoxification |
| HepG2 cells | [ |
| Chemoprevention | Human breast MCF-7 cells | [ | |||
| Chemoprevention | Japanese Daikon | Rats liver and lung | [ | ||
| Chemo preventive | Daikon sprouts | Rats’ hepatic enzymes | [ | ||
| Gluconapin | 3-Butenyl ITCs | Cytotoxicity | Human prostate cancer cells | [ | |
| Cytotoxicity | Synthetic | MCL-5 cells | [ | ||
| Anti-cancer, radical scavenging ability and increase ROS | human breast cancer (MCF-7,MDA-MB-231), prostate cancer (PC-3), lung cancer (A-549), cervical cancer (HeLa) and colon cancer (HCT 116) cells | [ | |||
| Glucoiberin | Cytotoxic activity |
| colon cancer cells | [ | |
| Glucocapparin | Methyl ITCs | Chemoprevention | HT-29 cell | [ | |
| Glucoarabin, Glucocamelinin | phase II detoxification enzyme induction, quinone reductase | Hepa1c1c7 cells | [ | ||
| α-4-Rhamnopyranosyloxy-benzyl GSs, & isomers | Induction of detoxifying enzymes |
| human hepatocellular carcinoma cell line -HepG2 cells | [ | |
| Glucoiberverin, Glucoerucin | Tumor growth inhibition, |
| HL60 (human promyelocytic leukaemia cell lines) | [ | |
|
| |||||
| Sinigrin | Allyl ITCs | Antifibrotic activity | Synthetic | [ | |
| Antiglycation | Synthetic | [ | |||
| Glucoraphenin, Glucoraphasatin | Sulforaphene, Raphasatin | Blood sugar control |
| [ | |
| Glucoraphanin, Glucoerucin | Sulforaphane, | Suppress mutagenecity | Synthetic | [ | |
| progoitrin, glucoraphanin, glucoalyssin, gluconapin, glucoerucin, glucoberteroin, glucobrassicanapin | Bone formation | [ | |||
|
| |||||
|
| |||||
| Glucobrassicin | Indole-3 carbinol | Biocide | Synthetic | [ | |
|
| |||||
| Glucobrassicin | Antioxidant | [ | |||
| Curly kale leaves | [ | ||||
|
| [ | ||||
|
| |||||
| Glucobrassicin | Indole-3-carbinol | Chemoprevention | Synthetic | Rats’ hepatic and kidney | [ |
| 3,3′-Diindolylmethane | Enhances level of reduced-glutathione | Synthetic | Rats heart and bone marrow | [ | |
|
| |||||
| Glucobrassicin, neoglucobrassicin | Bone formation | [ | |||
|
| |||||
| Gluconasturtiin | Phenethyl ITCs | Biocide | Synthetic | [ | |
| Larvicidal |
| [ | |||
| Glucotropaeolin, | Benzyl ITCs | Biocide | Synthetic | [ | |
| Glucolimnanthin | 3-ethoxybenzyl ITCs | Bio-herbicide |
| Lettuce | [ |
| GMG | Moringin | Insect deterrence |
| [ | |
| Phenyl ITCs | Herbicidal | Synthetic | [ | ||
|
| |||||
| GMG | Moringin | Antimicrobial |
| [ | |
| Gluconasturtiin | Phenylethyl ITCs | Antifungal |
|
| [ |
| Antimicrobial |
| [ | |||
| Antibacterial | Synthetic | [ | |||
| Antimicrobial | Cruciferous plant | methicillin resistant S | [ | ||
| Antimicrobial | Synthetic | Pig aeromonas intestinal bacteria | [ | ||
| Antifungal | Synthetic |
| [ | ||
| Glucotropaeolin | Benzyl ITCs | Bactericidal | Synthetic |
| [ |
| Antimicrobial | Synthetic | Antimicrobial | [ | ||
| Antimicrobial | Pig aeromonas bacteria | [ | |||
| Antifungal | Synthetic |
| [ | ||
| Glucobarbarin | Larvicidal |
| [ | ||
| Antifungal |
|
| [ | ||
| 5- Phenylpentyl ITCs | Antimicrobial, cytotoxic & antispasmodic |
|
| [ | |
|
| |||||
| GMG | Antioxidant |
| [ | ||
|
| |||||
| Phenyl ITCs | Anti-inflammatory | Synthetic | [ | ||
| Gluconasturtiin | Phenethyl ITCs | Anti-inflammatory | Synthetic | [ | |
| GMG | Moringin | Anti-inflammatory |
| [ | |
| 3,4-Dimethoxyphenyl | Anti-inflammatory | Synthetic | [ | ||
| 3-methoxyphenyl ITCS | Anti-inflammatory | synthetic | [ | ||
|
| |||||
| GMG | cytotoxicity |
| human colon adenocarcinoma grade II cells | [ | |
| Inhibit cells proliferation | Hep3B Liver Cancer Cells | [ | |||
| Anticancer | human malignant astrocytoma cell | [ | |||
| Gluconasturtiin | Phenethyl ITCs | Anti-cancer, radical scavenging ability and increase ROS | human breast cancer (MCF-7 and MDA-MB-231), prostate cancer (PC-3), lung cancer (A-549), cervical cancer (HeLa) and colon cancer (HCT 116) lines | [ | |
| Chemoprevention | Synthetic | Rats’ hepatic and kidney | [ | ||
| Chemoprevention | Synthetic | prostate cancer cells | [ | ||
| Anti-cancer, anti-melanoma | HepG2 human liver carcinoma and BB16F10 mice melanoma cell line | [ | |||
| Inhibit multiple myeloma growth | Synthetic | multiple myeloma cells | [ | ||
| Glucotropaeolin | Benzyl ITCs | Anticancer activity | human lung cancer H69 cell | [ | |
| Inhibit growth | Synthetic | multiple myeloma cells | [ | ||
| Benzyl and Phenyl ITCs | Antimetastatic | Synthetic | MDA-MB-231 (breast), Caski (cervical), A549 (lung), and U2OS (osteosarcoma) cell lines | [ | |
| A, β-dialkoxyphosphoryl | Antiproliferative activity | Synthetic | Lung cancer cells | [ | |
| 3-Methoxybenzyl ITCs, | Photoprotective |
| human skin cells | [ | |
| 5- Phenylpentyl ITCs | Antimicrobial, cytotoxic & antispasmodic |
|
| [ | |
|
| |||||
| Gluconasturtiin | Bone formation | [ | |||
| Phenethyl ITCs | Suppress mutagenecity | Synthetic | [ | ||
| Phenyl ITCs | Anti-inflammatory, cholinesterase inhibitory | Synthetic | [ | ||
Summary of some preclinical and clinical studies evaluating the health benefits of GSs and GSHPs.
| Patient’s Condition | Participants Enrolled | Groups and Doses | Duration | Analysed | Clinical Outcomes | Results | Reference |
|---|---|---|---|---|---|---|---|
| Melanoma | 17 | 3 groups, 3 oral doses (50,100, 200 µmoles) of broccoli sprouts extract containing sulforaphane (SFN) | 28 days | 17 | sulforaphane levels in plasma and skin, plasma cytokines, Safety, tissue proteomics | Detectable SFN in plasma, cytokines decreased, extracts tolerated up to 200 µmol, increased tumor suppressors | [ |
| Type 2 diabetes patients | 81 | 3 groups (2 received 10 g/day (d) broccoli sprout powder (BSP) and 5 g/d BSP and the third received the placebo | 4 weeks | 72 | Insulin concentration, fasting serum glucose, glucose: insulin ratio, homeostasis model of insulin resistance index | 10 g/d BSP significantly decreased serum insulin concentration, and improved insulin resistance in patients | [ |
| Low and intermediate risk prostate cancer patients | 61 | 3 groups received each 300 mL of different broccoli soup (rich in glucoraphanin) weekly | 12 months | 48 | Tissues examination/prostate pathology and RNA sequencing analysis for gene expression | Reduction of prostate cancer progression. Soups with high glucoraphanin content caused suppression in expression. | [ |
| Patients with recurrent prostate cancer | 20 | 200 µmoles/day of sulforaphane rich extract broccoli sprouts | 20 weeks | 16 | Safety of doses, Prostate specific antigen (PSA)% levels | Treatment was safe, exhibited anti-tumor potential, majority of patients didn’t get reduced PSA levels | [ |
| Asthmatic patients | 51 | 100 µmoles/day of sulforaphane rich broccoli sprouts extract | 14 days | 45 | Pulmonary functions, NAD(P)H quinone dehydrogenase-1 gene expression, safety | Enhanced bronchoconstrictor effects, increased gene expression also enhanced broncho-protection | [ |
| Women with abnormal mammograms | 54 | 2 groups; group1: (2 pills, 3 times/day of 30 mg glucoraphanin), group 2 placebo | 2 to 8 weeks | 48 | Sulforaphane in blood and urine, tissue biomarkers | Safe but not efficient to produce the changes in breast tissue tumor biomarkers | [ |
| Schizophrenia | 10 | 3 tablets/30 mg of Sulforaphane per day | 8 weeks | 7 | Evaluation of Symptoms using positive and negative syndrome scale and cognitive function | Sulforaphane potentially improved cognitive function | [ |
Improving GSs/ GSHPs and bioactivity in plant.
| Treatment/factor | Plant | GSs | Biological Activity | Reference |
|---|---|---|---|---|
| Sodium chloride | Radish sprouts | Total GSs, Glucoraphasatin | Antioxidant activity | [ |
| Salinity and carbon dioxide |
| Indolic GSs, aliphatic GSs respectively | - | [ |
| Sulphur salt supplementation | Total GSs, progoitrin, glucoerucin, glucobrassicin, glucohirsutin and 4- methoxybrassicin | Antioxidant, anti- proliferative | [ | |
| MeJA |
| gluconasturtiin, glucobrassicin, neoglucobrassicin, glucoraphanin | Quinone reductase | [ |
| Broccoli florets | glucobrassicin, neoglucobrassicin, gluconasturtiin | Quinone reductase | [ | |
| 1-methoxy-3-indolylmethyl GSs | Mutagenecity | [ | ||
| MeJA, high temperature, water stress | Broccoli cultivars | Total GSs | Quinone reductase | [ |
| GA3 with glucose |
| Indolic GSs | Antioxidant | [ |
| JA | Glucoraphanin | Not evaluated | [ | |
| Selenium | Broccoli sprouts | Sulforaphane | Not evaluated | [ |
| Nitrogen nutrition (Ammonium) | GSs | Not evaluated | [ | |
| Ozone | Sinigrin | Antioxidant | [ | |
| 6-benzylaminopurine |
| Total GSs and sulforaphane | Antioxidant | [ |
| Green LED light |
| Total GSs | [ | |
| Larval infestation | Indole GSs | [ | ||
|
| GSs | Bacterial pathogens attack | [ |
Improving GSs/ GSHPs bioavailability and bioactivity.
| Treatment | Source | Effects | Biological Activity | |
|---|---|---|---|---|
| Mild heat treatment | Myrosinase enzyme activity | [ | ||
| Continuous consumption | Broccoli | Total ITCs in colon and caecum levels of male mice | Quinone oxidoreductase | [ |
| Exogenous myrosinase treatment | Broccoli sprouts | Sulforaphane in diet | Sulforaphane Plasma levels | [ |
| Powdered mustard seeds | Sulforaphane in processed vegetables | - | [ |